XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.2
Accounts Receivable
6 Months Ended
Jun. 30, 2019
Receivables [Abstract]  
Accounts Receivable
Accounts Receivable

As of June 30, 2019, the Company had accounts receivable of $4.3 million, which relates to royalty revenue from the sales of NARCAN®. As of December 31, 2018 the Company had accounts receivable of $4.5 million, which relates to royalty revenue from the sales of NARCAN®.